FASTINOV announced its presence at the 32nd European Congress of Clinical Microbiology and Infectious Diseases in Lisbon. ECCMID brought together an international community working on infectious diseases, laboratory diagnostics and antimicrobial resistance.
Putting speed in context
The congress was an opportunity to discuss the clinical and laboratory value of reducing the time required to obtain antimicrobial susceptibility information. FASTINOV presented its ultra-rapid approach as part of the wider effort to support earlier, more targeted treatment decisions.
An international audience
Participation at ECCMID connected FASTINOV with researchers, clinicians, laboratory professionals and potential partners from across Europe and beyond. These conversations helped place the company’s technology within the broader development of faster microbiology workflows.
ECCMID in Lisbon gave FASTINOV an international platform to discuss ultra-rapid AST and the response to antimicrobial resistance.